Published in Hepatol Int on November 20, 2008
A Validation Cohort for ACLF Diagnosis and Prognosis (Ch-CANONIC-Val) | NCT03641872
The global burden of liver disease: the major impact of China. Hepatology (2014) 4.23
Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial. PLoS Med (2014) 2.74
The NLRP3 Inflammasome and IL-1β Accelerate Immunologically Mediated Pathology in Experimental Viral Fulminant Hepatitis. PLoS Pathog (2015) 2.04
Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther (2011) 1.97
Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure (ACLF). Dig Dis Sci (2010) 1.87
Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure. Dig Dis Sci (2010) 1.78
Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010. Gastroenterology (2015) 1.69
Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol (2013) 1.55
Hepatic decompensation likely attributable to simeprevir in patients with advanced cirrhosis. Dig Dis Sci (2014) 1.27
Liver transplantation for acute-on-chronic liver failure. Hepatol Int (2009) 1.23
Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis. J Viral Hepat (2010) 1.13
Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure. J Gastroenterol (2010) 1.13
Acute-on-chronic liver failure. Clin Mol Hepatol (2013) 1.03
Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med (2012) 1.01
Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study. Crit Care (2012) 0.99
Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Clin Exp Med (2011) 0.98
Liver: How can acute-on-chronic liver failure be accurately identified? Nat Rev Gastroenterol Hepatol (2013) 0.98
The balance between intrahepatic IL-17(+) T cells and Foxp3(+) regulatory T cells plays an important role in HBV-related end-stage liver disease. BMC Immunol (2011) 0.98
Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis. BMC Gastroenterol (2011) 0.95
Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome. World J Gastroenterol (2014) 0.94
Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure. PLoS One (2013) 0.93
Acute-on-Chronic Liver Failure. Clin Gastroenterol Hepatol (2015) 0.92
Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis. Hepatology (2012) 0.91
Dynamic changes of clinical features that predict the prognosis of acute-on-chronic hepatitis B liver failure: a retrospective cohort study. Int J Med Sci (2013) 0.89
Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: a single-center experience. Medicine (Baltimore) (2014) 0.89
Effects of nucleoside analogue on patients with chronic hepatitis B-associated liver failure: meta-analysis. PLoS One (2013) 0.87
Bench-to-beside review: acute-on-chronic liver failure - linking the gut, liver and systemic circulation. Crit Care (2011) 0.87
Acute-on-chronic liver failure: a review. Ther Clin Risk Manag (2014) 0.87
Predictors of the outcomes of acute-on-chronic hepatitis B liver failure. World J Gastroenterol (2012) 0.87
Does antiviral therapy reduce complications of cirrhosis? World J Gastroenterol (2014) 0.86
Clinical benefit of liver stiffness measurement at 3 months after Kasai hepatoportoenterostomy to predict the liver related events in biliary atresia. PLoS One (2013) 0.85
Hepatitis E- Is it a risk to transfusion safety? Asian J Transfus Sci (2013) 0.85
Correlation of aspartate aminotransferase/platelet ratio index with hepatic venous pressure gradient in cirrhosis. United European Gastroenterol J (2014) 0.84
Amelioration of liver injury by continuously targeted intervention against TNFRp55 in rats with acute-on-chronic liver failure. PLoS One (2013) 0.84
Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failure. Mediators Inflamm (2015) 0.84
The sterile inflammation in the exacerbation of HBV-associated liver injury. Mediators Inflamm (2015) 0.83
The etiology of Ebola virus disease-like illnesses in Ebola virusnegative patients from Sierra Leone. Oncotarget (2016) 0.83
Phenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF). J Transl Med (2012) 0.83
Epidemiological and clinical features of hepatitis B virus related liver failure in China. World J Gastroenterol (2011) 0.83
Change in model for end-stage liver disease score at two weeks, as an indicator of mortality or liver transplantation at 60 days in acute-on-chronic liver failure. Gastroenterol Rep (Oxf) (2014) 0.83
Restoring the Treg cell to Th17 cell ratio may alleviate HBV-related acute-on-chronic liver failure. World J Gastroenterol (2013) 0.83
Dynamic changes of lipopolysaccharide levels in different phases of acute on chronic hepatitis B liver failure. PLoS One (2012) 0.83
Sonoclot signature analysis in patients with liver disease and its correlation with conventional coagulation studies. Adv Hematol (2013) 0.82
Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure. Dig Dis Sci (2011) 0.82
Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation. World J Gastroenterol (2014) 0.82
Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management. World J Gastroenterol (2015) 0.82
Hepatitis E and Acute-on-Chronic Liver Failure. J Clin Exp Hepatol (2013) 0.82
Acute-on-chronic liver failure: terminology, mechanisms and management. Nat Rev Gastroenterol Hepatol (2016) 0.82
Upregulated Expression of A20 on Monocytes is Associated With Increased Severity of Acute-on-Chronic Hepatitis B Liver Failure: A Case-Control Study. Medicine (Baltimore) (2015) 0.81
Enhanced peripheral γδT cells cytotoxicity potential in patients with HBV-associated acute-on-chronic liver failure might contribute to the disease progression. J Clin Immunol (2012) 0.81
Improved survival ratios correlate with myeloid dendritic cell restoration in acute-on-chronic liver failure patients receiving methylprednisolone therapy. Cell Mol Immunol (2012) 0.81
Plasma Interleukin-10: A Likely Predictive Marker for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Hepat Mon (2014) 0.81
Downgrading MELD improves the outcomes after liver transplantation in patients with acute-on-chronic hepatitis B liver failure. PLoS One (2012) 0.81
Associations between hepatitis B virus basal core promoter/pre-core region mutations and the risk of acute-on-chronic liver failure: a meta-analysis. Virol J (2015) 0.80
Conditional survival estimate of acute-on-chronic hepatitis B liver failure: a dynamic prediction based on a multicenter cohort. Oncotarget (2015) 0.80
Efficacy of lamivudine or entecavir on acute exacerbation of chronic hepatitis B. Int J Med Sci (2011) 0.80
Two sides of one coin: massive hepatic necrosis and progenitor cell-mediated regeneration in acute liver failure. Front Physiol (2015) 0.80
Entecavir versus Lamivudine therapy for patients with chronic hepatitis B-associated liver failure: a meta-analysis. Hepat Mon (2014) 0.80
Serum thymosin beta4 levels in patients with hepatitis B virus-related liver failure. World J Gastroenterol (2010) 0.80
Hepatic stellate cells are involved in the pathogenesis of acute-on-chronic liver failure (ACLF). Virchows Arch (2012) 0.80
Adult Living Donor Liver Transplantation for Acute-on-Chronic Liver Failure in High- Model for End-Stage Liver Disease Score Patients. Am J Transplant (2017) 0.80
Acute-on-Chronic Liver Failure (ACLF) in Coastal Eastern India: "A Single-Center Experience". J Clin Exp Hepatol (2015) 0.80
Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF). Virchows Arch (2011) 0.79
Characterization of Full-Length Genomes of Hepatitis B Virus Quasispecies in Sera of Patients at Different Phases of Infection. J Clin Microbiol (2015) 0.79
Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure. World J Gastroenterol (2013) 0.79
Is liver biopsy necessary in the management of alcoholic hepatitis? World J Gastroenterol (2013) 0.79
Acute-on-Chronic Liver Failure: Recent Concepts. J Clin Exp Hepatol (2014) 0.79
Impacts of pretransplant infections on clinical outcomes of patients with acute-on-chronic liver failure who received living-donor liver transplantation. PLoS One (2013) 0.79
Defining acute-on-chronic liver failure: East, West or Middle ground? World J Hepatol (2015) 0.79
Severe alcoholic hepatitis-current concepts, diagnosis and treatment options. World J Hepatol (2014) 0.79
Severe hepatic necrosis of unknown causes following ABO-incompatible liver transplantation. World J Gastroenterol (2013) 0.79
Association of Hepatitis B Virus Mutations of A1846T and C1913A/G With Acute-on-Chronic Liver Failure Development From Different Underlying Chronic Liver Diseases. Hepat Mon (2013) 0.79
Establishment and validation of ALPH-Q score to predict mortality risk in patients with acute-on-chronic hepatitis B liver failure: a prospective cohort study. Medicine (Baltimore) (2015) 0.79
Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation. Int J Mol Sci (2015) 0.78
Management of chronic hepatitis B in severe liver disease. World J Gastroenterol (2014) 0.78
Predictors of outcome in acute-on-chronic liver failure in children. Hepatol Int (2010) 0.78
Early warning and clinical outcome prediction of acute-on-chronic hepatitis B liver failure. World J Gastroenterol (2015) 0.78
NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure. PLoS One (2015) 0.78
CD34+ hematopoietic stem cells mobilization, paralleled with multiple cytokines elevated in patients with HBV-related acute-on-chronic liver failure. Dig Dis Sci (2012) 0.78
Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure. World J Gastroenterol (2013) 0.78
The brain in acute on chronic liver failure. Metab Brain Dis (2014) 0.78
Combined adenovirus-mediated artificial microRNAs targeting mfgl2, mFas, and mTNFR1 protect against fulminant hepatic failure in mice. PLoS One (2013) 0.78
Prevalence and risk factors of acute-on-chronic liver failure in a single center from Argentina. World J Hepatol (2016) 0.77
Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease. World J Gastroenterol (2016) 0.77
Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study. Int J Med Sci (2013) 0.77
Circulating cell death biomarker: good candidates of prognostic indicator for patients with hepatitis B virus related acute-on-chronic liver failure. Sci Rep (2015) 0.77
Serum proteomics analysis and comparisons using iTRAQ in the progression of hepatitis B. Exp Ther Med (2013) 0.77
Prognoses of patients with acute-on-chronic hepatitis B liver failure are closely associated with altered SOCS1 mRNA expression and cytokine production following glucocorticoid treatment. Cell Mol Immunol (2014) 0.77
Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure. PLoS One (2015) 0.77
Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition. PLoS One (2016) 0.77
Sepsis in acute on chronic liver failure. Dig Dis Sci (2011) 0.77
Entecavir and lamivudine therapy for severe acute chronic hepatitis B. Exp Ther Med (2012) 0.77
Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B. Sci Rep (2016) 0.77
Expression of human glucocorticoid receptor in T lymphocytes in acute-on-chronic hepatitis B liver failure. Dig Dis Sci (2011) 0.77
Reduced cortical thickness in patients with acute-on-chronic liver failure due to non-alcoholic etiology. J Transl Med (2015) 0.76
Hemorrhagic Complications Following Abdominal Paracentesis in Acute on Chronic Liver Failure: A Propensity Score Analysis. Medicine (Baltimore) (2015) 0.76
On-treatment mortality predictors in chronic hepatitis B patients experiencing severe acute exacerbation: a prospective observational study. BMC Res Notes (2013) 0.76
Serum sphingolipids reflect the severity of chronic HBV infection and predict the mortality of HBV-acute-on-chronic liver failure. PLoS One (2014) 0.76
Association of Proton Pump Inhibitor Therapy with Hepatic Encephalopathy in Hepatitis B Virus-related Acute-on-Chronic Liver Failure. Hepat Mon (2014) 0.76
Two-tier regenerative response in liver failure in humans. Virchows Arch (2014) 0.76
AASLD position paper: the management of acute liver failure. Hepatology (2005) 5.09
Acute liver failure: redefining the syndromes. Lancet (1993) 4.99
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology (2007) 4.09
Acute liver failure: Summary of a workshop. Hepatology (2008) 3.49
Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med (2000) 3.47
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology (1993) 3.28
Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology (2002) 3.16
Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology (1996) 2.99
Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. J Hepatol (2005) 2.66
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial. Hepatology (2008) 2.55
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl (2000) 2.52
The systemic inflammatory response syndrome in acute liver failure. Hepatology (2000) 2.47
Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis (1986) 2.39
Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology (2007) 2.08
Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther (2006) 2.00
Complications of cirrhosis. I. Portal hypertension. J Hepatol (2000) 1.96
Rituximab-induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphoma. J Clin Oncol (2008) 1.69
Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis. Liver Transpl (2004) 1.64
Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure. Transplantation (2003) 1.61
ADMA correlates with portal pressure in patients with compensated cirrhosis. Eur J Clin Invest (2007) 1.59
The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest (2003) 1.58
Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol (2006) 1.55
Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl (2004) 1.50
Pre-transplant optimization by Molecular Adsorbent Recirculating System in patients with severely decompensated chronic liver disease. Indian J Gastroenterol (2007) 1.43
Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif (2002) 1.41
Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology (2001) 1.39
Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology (2002) 1.38
Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening? World J Gastroenterol (2006) 1.36
Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology (2007) 1.33
Hepatitis B: reflections on the current approach to antiviral therapy. J Hepatol (2008) 1.32
Superimposed acute hepatitis E infection in patients with chronic liver disease. Indian J Gastroenterol (2004) 1.31
Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest (2002) 1.28
Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology (1993) 1.28
Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol (2004) 1.28
Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology (1990) 1.26
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis (2007) 1.25
The pathophysiological basis of acute-on-chronic liver failure. Liver (2002) 1.24
Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab. Intern Med (2006) 1.23
Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol (1991) 1.21
Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care (2006) 1.21
Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval. J Gastroenterol Hepatol (2007) 1.17
Successful orthotopic liver transplantation for lamivudine-associated YMDD mutant hepatitis B virus. Gastroenterology (2000) 1.17
Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis. J Hepatol (2004) 1.17
Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care (2006) 1.10
Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease. J Gastroenterol Hepatol (2007) 1.08
Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis. Hepatology (2007) 1.07
Effects of artificial liver support system on patients with acute or chronic liver failure. Transplant Proc (2005) 1.07
Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma. Br J Dermatol (2006) 1.07
Risk factors for nonhepatic surgery in patients with cirrhosis. World J Surg (2003) 1.07
Application of Molecular Adsorbents Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome. Liver Int (2003) 1.07
Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation. Bone Marrow Transplant (2003) 1.06
Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery. Arch Surg (1997) 1.06
Late onset hepatic failure: clinical, serological and histological features. Hepatology (1986) 1.06
Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure. Liver Int (2003) 1.05
Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems. Cardiovasc Res (1998) 1.04
Outcome prediction for patients with cirrhosis of the liver in a medical ICU: a comparison of the APACHE scores and liver-specific scoringsystems. Intensive Care Med (1996) 1.02
Ischemia-modified albumin predicts mortality in ESRD. Am J Kidney Dis (2006) 1.01
Cytokines and liver failure: modification of TNF- and IL-6 in patients with acute on chronic liver decompensation treated with Molecular Adsorbent Recycling System (MARS). Acta Biomed (2003) 1.00
[Acute-on-chronic liver failure]. Ryoikibetsu Shokogun Shirizu (1995) 0.99
Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure. Liver Transpl (2007) 0.98
Utility of admission cardiac troponin and "Ischemia Modified Albumin" measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J (2006) 0.97
Accumulation of symmetric dimethylarginine in hepatorenal syndrome. Exp Biol Med (Maywood) (2006) 0.97
Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children. J Pediatr Gastroenterol Nutr (2005) 0.97
Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy. Scand J Infect Dis (2007) 0.94
Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma. Br J Haematol (2002) 0.93
Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. Clin Liver Dis (2007) 0.93
Hemodynamic studies in acute-on-chronic liver failure. Dig Dis Sci (2008) 0.92
Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B. World J Gastroenterol (2005) 0.91
Actin-free Gc globulin: a rapidly assessed biomarker of organ dysfunction in acute liver failure and cirrhosis. Liver Transpl (2007) 0.88
Short-term prognosis in critically ill patients with liver cirrhosis: an evaluation of a new scoring system. Eur J Gastroenterol Hepatol (2000) 0.88
Favorable outcome of orthotopic liver transplantation in a patient with subacute liver failure due to the emergence of a hepatitis B YMDD escape mutant virus. J Hepatol (2001) 0.88
Outcomes of patients with hepatitis B who developed antiviral resistance while on the liver transplant waiting list. Clin Gastroenterol Hepatol (2007) 0.87
Liver transplantation for severe acute liver failure after herbal medicine (Teucrium polium) administration. J Hepatol (1995) 0.86
Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure. Liver Int (2005) 0.86
Effect of artificial liver support system on patients with severe viral hepatitis: a study of four hundred cases. World J Gastroenterol (2004) 0.85
Economic evaluation and 1-year survival analysis of MARS in patients with alcoholic liver disease. Liver Int (2003) 0.85
MARS: a futile tool in centres without active liver transplant support. Liver Int (2007) 0.83
Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation -- a pilot study. Liver Int (2005) 0.82
Lamivudine for treatment of spontaneous exacerbation and reactivation after immunosuppressive therapy in patients with hepatitis B virus infection. Hepatogastroenterology (2007) 0.82
Long-term results of liver transplant in patients with chronic viral hepatitis-related liver disease in Singapore. Singapore Med J (2006) 0.79
International network of cancer genome projects. Nature (2010) 20.35
The sequence and de novo assembly of the giant panda genome. Nature (2009) 15.76
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09
Early liver transplantation for severe alcoholic hepatitis. N Engl J Med (2011) 8.50
Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med (2013) 7.48
Gene expression patterns in human liver cancers. Mol Biol Cell (2002) 6.93
Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell (2008) 6.48
The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med (2008) 6.41
Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology (2013) 5.88
Viral hepatitis C. Lancet (2003) 5.81
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. J Hepatol (2013) 5.64
Therapeutic hypothermia after out-of-hospital cardiac arrest in children. N Engl J Med (2015) 4.90
Viral hepatitis B. Lancet (2003) 4.86
Innovative approaches for designing and analyzing adaptive dose-ranging trials. J Biopharm Stat (2007) 4.78
Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery (2011) 4.40
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet (2012) 4.07
Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology (2004) 4.06
Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Natl Acad Sci U S A (2007) 3.84
Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology (2013) 3.55
Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol (2008) 3.50
Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology (2011) 3.45
Spleen stiffness in patients with cirrhosis in predicting esophageal varices. Am J Gastroenterol (2013) 3.39
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. Lancet Oncol (2011) 3.32
Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology (2008) 3.26
A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol (2013) 3.19
Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery (2011) 3.16
Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Ann Surg (2013) 3.11
Results of small incision lenticule extraction: All-in-one femtosecond laser refractive surgery. J Cataract Refract Surg (2011) 2.95
Dispelling myths in the treatment of hepatic encephalopathy. Lancet (2005) 2.86
Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer (2006) 2.71
Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology (2003) 2.71
Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy. Hepatology (2013) 2.66
Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut (2011) 2.65
Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology (2013) 2.64
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology (2003) 2.64
Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg (2006) 2.59
Distinct pathways of genomic progression to benign and malignant tumors of the liver. Proc Natl Acad Sci U S A (2007) 2.56
The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points. Ann Intern Med (2007) 2.52
Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron (2003) 2.51
Physics. Learning and scientific reasoning. Science (2009) 2.49
Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol (2004) 2.48
Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver. Hepatology (2012) 2.47
Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Hepatology (2012) 2.39
Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway. Blood (2009) 2.39
Design and characterization of programmable DNA nanotubes. J Am Chem Soc (2004) 2.38
Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res (2006) 2.32
11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective. J Nucl Med (2013) 2.29
Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell (2013) 2.28
Effect of lowering HBV DNA levels by initial antiviral therapy before adding immunomodulator on treatment of chronic hepatitis B. Am J Gastroenterol (2007) 2.25
Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection. Hepatology (2011) 2.25
Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol (2008) 2.24
A genome-wide meta-analysis of genetic variants associated with allergic rhinitis and grass sensitization and their interaction with birth order. J Allergy Clin Immunol (2011) 2.24
Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B. J Hepatol (2005) 2.19
Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy? Ann Surg (2012) 2.18
Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology (2002) 2.17
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res (2013) 2.12
A sphingosine-1-phosphate-activated calcium channel controlling vascular smooth muscle cell motility. Circ Res (2006) 2.12
HLA-DP and IL28B polymorphisms: influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B. Clin Infect Dis (2013) 2.11
Pulmonary complications after elective liver transplantation-incidence, risk factors, and outcome. Transplantation (2012) 2.11
Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol (2007) 2.11
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology (2013) 2.08
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results. Liver Transpl (2007) 2.08
Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology (2007) 2.08
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology (2002) 2.06
A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol (2007) 2.06
The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis. J Hepatol (2011) 2.05
Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma. Arch Surg (2011) 2.05
Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. Gastroenterology (2012) 2.03
Identification of local and circulating cancer stem cells in human liver cancer. Hepatology (2008) 2.02
Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg (2003) 2.02
Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol (2011) 1.99
Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg (2004) 1.99
Liver resection using a saline-linked radiofrequency dissecting sealer for transection of the liver. J Am Coll Surg (2005) 1.98
Evaluation of six commercial point-of-care tests for diagnosis of acute dengue infections: the need for combining NS1 antigen and IgM/IgG antibody detection to achieve acceptable levels of accuracy. Clin Vaccine Immunol (2011) 1.97
Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int (2008) 1.95
rRNA modifications in an intersubunit bridge of the ribosome strongly affect both ribosome biogenesis and activity. Mol Cell (2007) 1.95
Impact of new legislation on presumed consent on organ donation on liver transplant in Singapore: a preliminary analysis. Transplantation (2006) 1.94
Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia: report of a case. Hepatobiliary Pancreat Dis Int (2007) 1.93
The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol (2010) 1.93
Evidence of neutrophil functional defect despite inflammation in stable cirrhosis. J Hepatol (2011) 1.90
Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Ann Surg Oncol (2007) 1.89
Strigolactones are transported through the xylem and play a key role in shoot architectural response to phosphate deficiency in nonarbuscular mycorrhizal host Arabidopsis. Plant Physiol (2010) 1.89
Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med (2007) 1.89
Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation. Gastroenterology (2011) 1.89
Viral hepatitis in India. Natl Med J India (2006) 1.88
The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: a retrospective series of 24 patients. J Neuroimaging (2010) 1.88
Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am J Gastroenterol (2003) 1.88
Celiac disease: variations of presentations in adults. Indian J Gastroenterol (2007) 1.88
GSK3-TIP60-ULK1 signaling pathway links growth factor deprivation to autophagy. Science (2012) 1.84
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies. Gastroenterology (2013) 1.83
A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide. Proc Natl Acad Sci U S A (2009) 1.83